1388 studies found for:    "Diabetes mellitus type 1"
Show Display Options
Rank Status Study
1 Unknown  PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Conditions: Type 1 Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Insulin-Dependent
Interventions: Drug: PROCHYMAL®;   Drug: Placebo
2 Completed Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
Conditions: Type 1 Diabetes;   Preservation of Insulin Secretion;   Newly Diagnosed Type 1 Diabetes;   Canakinumab in Type 1 Diabetes
Intervention: Drug: canakinumab (anti IL-1beta)
3 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
4 Active, not recruiting The Influence of Partial Remission Phase of Type 1 Diabetes on Patient Outcome
Conditions: Diabetes Mellitus Type 1;   Remission of Type 1 Diabetes;   Chronic Complications of Diabetes
Intervention:
5 Recruiting Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type I;   Diabetes Mellitus, Insulin-Dependent, 1;   Type 1 Diabetes Mellitus;   Insulin-Dependent Diabetes Mellitus 1;   IDDM
Interventions: Drug: Imatinib Mesylate;   Drug: Placebo (For imatinib mesylate)
6 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Conditions: Type 1 Diabetes;   New Onset Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
7 Completed A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1;   Type 1 Diabetes Mellitus
Interventions: Drug: GSK189075;   Drug: placebo
8 Terminated
Has Results
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diabetes
Interventions: Drug: Insulin;   Drug: Lansoprazole;   Drug: Sitagliptin;   Biological: Diamyd;   Drug: GAD65 (Diamyd)
9 Enrolling by invitation Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM)
Condition: Diabetes Mellitus Type 1
Intervention: Biological: MSC exosomes.
10 Completed The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1
Condition: Diabetes Mellitus Type 1
Intervention: Drug: Vitamin D3
11 Completed Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: XOMA 052;   Drug: Placebo
12 Recruiting Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: Sitagliptin;   Drug: Exercise
13 Recruiting A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: BioChaperone insulin lispro;   Drug: Humalog®
14 Recruiting A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: BioChaperone insulin lispro 0.2U/Kg;   Drug: BioChaperone insulin lispro 0.1U/Kg;   Drug: BioChaperone insulin lispro 0.4U/Kg;   Drug: Humalog®
15 Completed Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: Insulin LISPRO;   Drug: recombinant human insulin
16 Recruiting A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: BioChaperone human insulin;   Drug: Huminsulin® Normal;   Drug: Humalog®
17 Completed Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
Condition: Type 1 Diabetes
Intervention:
18 Recruiting Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study
Condition: Diabetes Mellitus Type 1
Intervention: Other: Clamp-Mixed Meal Arm
19 Completed Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Sugar Pill
20 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years